Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 24 2021 - 4:35PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of
Foreign Private Issuer
Pursuant to Rule 13a-16 or
15d-16
of the Securities Exchange Act of 1934
Date of Report: May 24, 2021
Commission File Number: 001-36891
Cellectis S.A.
(Exact
Name of registrant as specified in its charter)
8, rue de la
Croix Jarry
75013 Paris, France
+33 1 81 69 16 00
(Address of principal executive office)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Cellectis S.A.
As previously announced, Cellectis S.A. (the Company) is hosting Cellectis Innovation Daysa virtual event comprising one hour-long
video webcast episodes made available at 10:00 a.m. (Eastern) on each day from May 24, 2021 through May 28, 2021. Each webcast episode will be made available on the Companys website and will be available for replay in the Investor
Relations section of the Companys website at: https://www.cellectis.com/en/investors/events-and-webcasts/.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
CELLECTIS SA
|
|
|
|
|
Date: May 24, 2021
|
|
|
|
By:
|
|
/s/ André Choulika
|
|
|
|
|
|
|
André Choulika
|
|
|
|
|
|
|
Chief Executive Officer
|
Cellectis (NASDAQ:CLLS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cellectis (NASDAQ:CLLS)
Historical Stock Chart
From Sep 2023 to Sep 2024